Component 18 – 9
200,000 ft²
200,000 ft²

capacity for advanced therapy process development
and cGMP manufacturing

capacity for advanced therapy process development
and cGMP manufacturing

Group 18322
Hundreds
Hundreds

of Class B and C Clean Rooms

of Class B and C Clean Rooms

Group 18323

Over

Over

300
300

experts in gene & cell therapy areas

experts in gene & cell therapy areas

Group 18324
20
20

state-of-the-art cGMP
production suites

state-of-the-art cGMP
production suites

previous arrow
next arrow

WHO WE ARE

Innately innovative

At Porton Advanced Solutions, we are committed to accelerating delivery of life-changing advanced therapies to patients. As a Cell and Gene Therapy CDMO company, we provide end-to-end biopharma solutions and services to our clients throughout the development and commercialization of their therapeutics.

Our goal is to improve availability and commercial viability of these life-changing treatments by accelerating therapeutic development through our unique, innovative approach.

Porton Advanced Solutions is a subsidiary of the leading CDMO Porton Pharma Solutions. Porton Pharma Solutions is globally recognized and trusted for its process innovation, supply chain performance and compliance with global quality and EHS standards.

Platforms

Expertise tailored to your needs

Our clients include a wide range of biotech and pharmaceutical companies, academic research institutes, and hospitals, each with unique needs spanning across discovery research, drug development, different clinical phases, and commercialization.


Our innovative, integrated approach enables us to respond to the full needs of each individual customer.
We provide end-to-end biopharma solutions according to each client’s needs across multiple therapeutic platforms.

Cell Therapy

Viral Vectors

Oncolytic Virus

Plasmid

OUR SERVICES

Dedicated, end-to-end support

We have been investing heavily in platform development across the Cell and Gene Therapy (C&GT) and Chemistry, Manufacturing, and Control (CMC) spaces.


Our dedicated process and analytical development teams have built up proprietary technologies for client’s licenses and robust platform-based USP/DSP tailored to client’s manufacturing needs.

Our offer includes C&GT engineering discovery research and technology licenses, process and analytical development, DS and DP cGMP manufacturing, and testing services.

Quality Assured

We adhere to strict control and assurance measures throughout to ensure we deliver exceptional quality products.

PROCESS DEVELOPMENTCGMP MANUFACTURINGLICENSES & DISCOVERYANALYTICAL DEVELOPMENTTESTINGSERVICE

QUALITY Assured

We adhere to strict control and assurance measures throughout to ensure we deliver exceptional quality products.

Innovation

november

01nov9:00 am03(nov 3)9:00 amCPhI Worldwide 2022 – A Smart Event

14nov(nov 14)9:00 am15(nov 15)9:00 amBiomanufacturing World Summet 2022

january

18jan(jan 18)9:00 am21(jan 21)9:00 amAdvanced Therapies Week 2023

X